{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:39:09Z","timestamp":1788950349705,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10096-020-03835-6","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"1231-1238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-5688","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiudi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanLi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqian","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"3835_CR1","doi-asserted-by":"publisher","first-page":"e0118369","DOI":"10.1371\/journal.pone.0118369","volume":"10","author":"C Reed","year":"2015","unstructured":"Reed C, Chaves SS, Daily Kirley P et al (2015) Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One 10:e0118369. https:\/\/doi.org\/10.1371\/journal.pone.0118369","journal-title":"PLoS One"},{"key":"3835_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/21645515.2016.1251537","volume":"13","author":"EW Thommes","year":"2017","unstructured":"Thommes EW, Kruse M, Kohli M et al (2017) Review of seasonal influenza in Canada: burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines. Hum Vaccin Immunother 13:867\u2013876. https:\/\/doi.org\/10.1080\/21645515.2016.1251537","journal-title":"Hum Vaccin Immunother"},{"key":"3835_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/irv.12533","volume":"12","author":"VJ Lee","year":"2018","unstructured":"Lee VJ, Ho ZJM, Goh EH et al (2018) Advances in measuring influenza burden of disease. Influenza Other Respir Viruses 12:3\u20139. https:\/\/doi.org\/10.1111\/irv.12533","journal-title":"Influenza Other Respir Viruses"},{"key":"3835_CR4","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2095\u20132128. https:\/\/doi.org\/10.1016\/S0140-6736(12)61728-0","journal-title":"Lancet"},{"key":"3835_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5365\/WPSAR.2017.8.1.002","volume":"8","author":"S Ly","year":"2017","unstructured":"Ly S, Arashiro T, Ieng V et al (2017) Establishing seasonal and alert influenza thresholds in Cambodia using the WHO method: implications for effective utilization of influenza surveillance in the tropics and subtropics. Western Pac Surveill Response J 8:22\u201332. https:\/\/doi.org\/10.5365\/WPSAR.2017.8.1.002","journal-title":"Western Pac Surveill Response J"},{"key":"3835_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.vaccine.2016.12.064","volume":"35","author":"BJ Cowling","year":"2017","unstructured":"Cowling BJ, Caini S, Chotpitayasunondh T et al (2017) Influenza in the Asia-Pacific region: findings and recommendations from the global influenza initiative. Vaccine 35:856\u2013864. https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.064","journal-title":"Vaccine"},{"key":"3835_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M von Itzstein","year":"1993","unstructured":"von Itzstein M, Wu WY, Kok GB et al (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418\u2013423. https:\/\/doi.org\/10.1038\/363418a0","journal-title":"Nature"},{"key":"3835_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","volume":"37","author":"G He","year":"1999","unstructured":"He G, Massarella J, Ward P (1999) Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet 37:471\u2013484. https:\/\/doi.org\/10.2165\/00003088-199937060-00003","journal-title":"Clin Pharmacokinet"},{"key":"3835_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","volume":"283","author":"JJ Treanor","year":"2000","unstructured":"Treanor JJ, Hayden FG, Vrooman PS et al (2000) Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 283:1016\u20131024. https:\/\/doi.org\/10.1001\/jama.283.8.1016","journal-title":"JAMA"},{"key":"3835_CR10","doi-asserted-by":"publisher","first-page":"f3039","DOI":"10.1136\/bmj.f3039","volume":"346","author":"South East Asia Infectious Disease Clinical Research Network","year":"2013","unstructured":"South East Asia Infectious Disease Clinical Research Network (2013) Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ 346:f3039. https:\/\/doi.org\/10.1136\/bmj.f3039","journal-title":"BMJ"},{"key":"3835_CR11","doi-asserted-by":"publisher","first-page":"e6051","DOI":"10.1371\/journal.pone.0006051","volume":"4","author":"W Hanshaoworakul","year":"2009","unstructured":"Hanshaoworakul W, Simmerman JM, Narueponjirakul U et al (2009) Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 4:e6051. https:\/\/doi.org\/10.1371\/journal.pone.0006051","journal-title":"PLoS One"},{"key":"3835_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/523584","volume":"45","author":"A McGeer","year":"2007","unstructured":"McGeer A, Green KA, Plevneshi A et al (2007) Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 45:1568\u20131575. https:\/\/doi.org\/10.1086\/523584","journal-title":"Clin Infect Dis"},{"key":"3835_CR13","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2165\/11641110-000000000-00000","volume":"72","author":"IG Barr","year":"2012","unstructured":"Barr IG, Jelley LL (2012) The coming era of quadrivalent human influenza vaccines: who will benefit? Drugs 72:2177\u20132185. https:\/\/doi.org\/10.2165\/11641110-000000000-00000","journal-title":"Drugs"},{"key":"3835_CR14","doi-asserted-by":"publisher","first-page":"e0222381","DOI":"10.1371\/journal.pone.0222381","volume":"14","author":"S Caini","year":"2019","unstructured":"Caini S, Kusznierz G, Garate VV et al (2019) The epidemiological signature of influenza B virus and its B\/Victoria and B\/Yamagata lineages in the 21st century. PLoS One 14:e0222381. https:\/\/doi.org\/10.1371\/journal.pone.0222381","journal-title":"PLoS One"},{"key":"3835_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12879-019-4181-2","volume":"19","author":"X Fu","year":"2019","unstructured":"Fu X, Zhou Y, Wu J et al (2019) Clinical characteristics and outcomes during a severe influenza season in China during 2017-2018. BMC Infect Dis 19:668. https:\/\/doi.org\/10.1186\/s12879-019-4181-2","journal-title":"BMC Infect Dis"},{"key":"3835_CR16","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/22221751.2019.1648183","volume":"8","author":"W Shi","year":"2019","unstructured":"Shi W, Ke C, Fang S et al (2019) Co-circulation and persistence of multiple A\/H3N2 influenza variants in China. Emerg Microbes Infect 8:1157\u20131167. https:\/\/doi.org\/10.1080\/22221751.2019.1648183","journal-title":"Emerg Microbes Infect"},{"key":"3835_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.medmal.2017.11.007","volume":"48","author":"A Chagvardieff","year":"2018","unstructured":"Chagvardieff A, Persico N, Marmillot C et al (2018) Prospective comparative study of characteristics associated with influenza A and B in adults. Med Mal Infect 48:180\u2013187. https:\/\/doi.org\/10.1016\/j.medmal.2017.11.007","journal-title":"Med Mal Infect"},{"key":"3835_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/ciu269","volume":"59","author":"S Su","year":"2014","unstructured":"Su S, Chaves SS, Perez A et al (2014) Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin Infect Dis 59:252\u2013255. https:\/\/doi.org\/10.1093\/cid\/ciu269","journal-title":"Clin Infect Dis"},{"key":"3835_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/cid\/ciu269","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG et al (2015) Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415\u2013427. https:\/\/doi.org\/10.1093\/cid\/ciu269","journal-title":"N Engl J Med"},{"key":"3835_CR20","doi-asserted-by":"publisher","first-page":"e018709","DOI":"10.1136\/bmjopen-2017-018709","volume":"8","author":"L Chen","year":"2018","unstructured":"Chen L, Zhou F, Li H et al (2018) Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. BMJ Open 8:e018709. https:\/\/doi.org\/10.1136\/bmjopen-2017-018709","journal-title":"BMJ Open"},{"key":"3835_CR21","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/cid\/ciz101","volume":"69","author":"T Lytras","year":"2019","unstructured":"Lytras T, Mouratidou E, Andreopoulou A et al (2019) Effect of early Oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multiseason cohort study. Clin Infect Dis 69:1896\u20131902. https:\/\/doi.org\/10.1093\/cid\/ciz101","journal-title":"Clin Infect Dis"},{"key":"3835_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/irv.12363","volume":"10","author":"SG Muthuri","year":"2016","unstructured":"Muthuri SG, Venkatesan S, Myles PR et al (2016) Impact of neuraminidase inhibitors on influenza a(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. Influenza Other Respir Viruses 10:192\u2013204. https:\/\/doi.org\/10.1111\/irv.12363","journal-title":"Influenza Other Respir Viruses"},{"key":"3835_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.11613\/BM.2014.022","volume":"24","author":"MS Thiese","year":"2014","unstructured":"Thiese MS (2014) Observational and interventional study design types; an overview. Biochem Med (Zagreb) 24:199\u2013210. https:\/\/doi.org\/10.11613\/BM.2014.022","journal-title":"Biochem Med (Zagreb)"},{"key":"3835_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jiac.2016.06.002","volume":"22","author":"H Ikematsu","year":"2016","unstructured":"Ikematsu H, Kawai N, Iwaki N et al (2016) In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010-2011 to 2014-2015 Japanese influenza seasons. J Infect Chemother 22:599\u2013604. https:\/\/doi.org\/10.1016\/j.jiac.2016.06.002","journal-title":"J Infect Chemother"},{"key":"3835_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jiac.2018.01.013","volume":"24","author":"N Ishiguro","year":"2018","unstructured":"Ishiguro N, Koseki N, Kaiho M et al (2018) Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza a and B in the 2014-2015 to 2016-2017 influenza seasons in Japan. J Infect Chemother 24:449\u2013457. https:\/\/doi.org\/10.1016\/j.jiac.2018.01.013","journal-title":"J Infect Chemother"},{"key":"3835_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1086\/505868","volume":"43","author":"N Kawai","year":"2006","unstructured":"Kawai N, Ikematsu H, Iwaki N et al (2006) A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 43:439\u2013444. https:\/\/doi.org\/10.1086\/505868","journal-title":"Clin Infect Dis"},{"key":"3835_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jiac.2018.04.013","volume":"24","author":"H Ikematsu","year":"2018","unstructured":"Ikematsu H, Kawai N, Iwaki N et al (2018) Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016\/17 Japanese influenza season; comparison with the 2011\/12 to 2015\/16 seasons. J Infect Chemother 24:718\u2013724. https:\/\/doi.org\/10.1016\/j.jiac.2018.04.013","journal-title":"J Infect Chemother"},{"key":"3835_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2213-2600(16)30435-0","volume":"5","author":"FM Marty","year":"2017","unstructured":"Marty FM, Vidal-Puigserver J, Clark C et al (2017) Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial. Lancet Respir Med 5:135\u2013146. https:\/\/doi.org\/10.1016\/S2213-2600(16)30435-0","journal-title":"Lancet Respir Med"},{"key":"3835_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/thx.2009.130799","volume":"65","author":"N Lee","year":"2010","unstructured":"Lee N, Choi KW, Chan PK et al (2010) Outcomes of adults hospitalised with severe influenza. Thorax 65:510\u2013515. https:\/\/doi.org\/10.1136\/thx.2009.130799","journal-title":"Thorax"},{"key":"3835_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcv.2015.03.018","volume":"67","author":"MP Fairchok","year":"2015","unstructured":"Fairchok MP, Chen WJ, Arnold JC et al (2015) Neuraminidase inhibitor therapy in a military population. J Clin Virol 67:17\u201322. https:\/\/doi.org\/10.1016\/j.jcv.2015.03.018","journal-title":"J Clin Virol"},{"key":"3835_CR31","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1186\/cc9324","volume":"14","author":"N Hagau","year":"2010","unstructured":"Hagau N, Slavcovici A, Gonganau DN et al (2010) Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 14:R203. https:\/\/doi.org\/10.1186\/cc9324","journal-title":"Crit Care"},{"key":"3835_CR32","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1073\/pnas.0711942105","volume":"105","author":"BJ Zheng","year":"2008","unstructured":"Zheng BJ, Chan KW, Lin YP et al (2008) Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza a\/H5N1 virus. Proc Natl Acad Sci U S A 105:8091\u20138096. https:\/\/doi.org\/10.1073\/pnas.0711942105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3835_CR33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/cid\/cis636","volume":"55","author":"JK Louie","year":"2012","unstructured":"Louie JK, Yang S, Acosta M et al (2012) Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis 55:1198\u20131204. https:\/\/doi.org\/10.1093\/cid\/cis636","journal-title":"Clin Infect Dis"},{"key":"3835_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10096-016-2809-3","volume":"36","author":"A Kossyvakis","year":"2017","unstructured":"Kossyvakis A, Mentis AA, Tryfinopoulou K et al (2017) Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment. Eur J Clin Microbiol Infect Dis 36:361\u2013371. https:\/\/doi.org\/10.1007\/s10096-016-2809-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3835_CR35","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.1038\/s41598-017-07433-z","volume":"7","author":"PNQ Pascua","year":"2017","unstructured":"Pascua PNQ, Mostafa HH, Marathe BM et al (2017) Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection. Sci Rep 7:7345. https:\/\/doi.org\/10.1038\/s41598-017-07433-z","journal-title":"Sci Rep"},{"key":"3835_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","volume":"44","author":"G Moreno","year":"2018","unstructured":"Moreno G, Rodr\u00edguez A, Reyes LF et al (2018) Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med 44:1470\u20131482. https:\/\/doi.org\/10.1007\/s00134-018-5332-4","journal-title":"Intensive Care Med"},{"key":"3835_CR37","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","volume":"385","author":"J Dobson","year":"2015","unstructured":"Dobson J, Whitley RJ, Pocock S et al (2015) Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385:1729\u20131737. https:\/\/doi.org\/10.1016\/S0140-6736(14)62449-1","journal-title":"Lancet"},{"key":"3835_CR38","doi-asserted-by":"publisher","first-page":"CD008965","DOI":"10.1002\/14651858.CD008965.pub4","volume":"4","author":"T Jefferson","year":"2014","unstructured":"Jefferson T, Jones MA, Doshi P et al (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 4:CD008965. https:\/\/doi.org\/10.1002\/14651858.CD008965.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"3835_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/fampra\/cms059","volume":"30","author":"MH Ebell","year":"2013","unstructured":"Ebell MH, Call M, Shinholser J (2013) Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract 30:125\u2013133. https:\/\/doi.org\/10.1093\/fampra\/cms059","journal-title":"Fam Pract"},{"key":"3835_CR40","unstructured":"National Health Commission of the People\u2019s Republic of China. Clinical guidance for patients with influenza infection. http:\/\/wwwnhcgovcn\/xxgk\/pages\/viewdocumentjsp?%20dispatchDate=&staticUrl=%2Fyzygj%2Fpqt%2F201811%2Fdd748b43df0640e0bf%2033c526ca8c9ddfshtml&wenhao=%E5%9B%BD%E5%8D%AB%E5%8A%9E%20%E5%8C%BB%E5%87%BD%E3%80%942018%E3%80%951020%E5%8F%B7%20&utitle=%E5%85%B3%E4%BA%8E%E8%BF%9B%E4%B8%80%E6%AD%%20A5%E5%8A%A0%E5%BC%BA%E6%B5%81%E8%A1%8C%E6%80%A7%E6%%2084%9F%E5%86%92%E5%8C%BB%E7%96%97%E5%B7%A5%E4%BD%9C%E7%20%9A%84%E9%80%9A%E7%9F%A5&topictype=&topic=&publishedOrg=%E5%%208C%BB%E6%94%BF%E5%8C%BB%E7%AE%A1%E5%B1%80&indexNum=%20000013610%2F2018\u201300308&manuscriptId=dd748b43df0640e0bf33c526ca%208c9ddf"},{"key":"3835_CR41","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy874","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki TM, Bernstein HH, Bradley JS et al (2019) Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak Management of Seasonal Influenza A. Clin Infect Dis 68:e1\u2013e47. https:\/\/doi.org\/10.1093\/cid\/ciy874","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-020-03835-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T02:19:25Z","timestamp":1612491565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-020-03835-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["3835"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03835-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.The study design was approved by the Ethics Committee of Chao-Yang Hospital (No.2015\u201386).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}